(1) Objective:To summarize the etiological factors of neonatal hyperbilirubinemia.

(2) Conclusions Neonatal hyperbilirubinemia can cause hearing injury in neonates.

(3) Objective To of myocardial enzymes in newborn with hyperbilirubinemia.

(4) Conclusions Hyperbilirubinemia is high-risk population of hearing disorder.

(5) Methods Put 58 people of hyperbilirubinemia in patients with chronic hepatitis B to divide randomly into treatment group and matched group.

(6) Objective To evaluate the damage of hyperbilirubinemia to brain and hearing by brainstem audio electric potential (BAEP) screening in neonates with hyperbilirubinemia but without kernicterus.

(7) Neonatal hyperbilirubinemia is one of the most common diseases in neonatal period. Its morbidity has been increasing, and as time goes on, the pathogenic factors changed as well.

(8) Objective:To evaluate the relationship between the incidence of hyperbilirubinemia and the degree of the G6PD (glucose-6 phosphate dehydrogenate) deficiency.

(9) Analysis of 70 new-borns with hyperbilirubinemia showed that 42.9 percent due to infection and 28.5 percent were caused by glucose-6-phosphate dehydrogenase deficiency.

(10) There is an increased incidence of hyperbilirubinemia hypocalcemia and erythremia.

(11) Conclusions Hyperbilirubinemia in BMJ infants is lower in their humoral immunology status.

(12) The influence of hypothyroid function in neonatal with hyperbilirubinemia were observed after treatment and before treatment.

(13) AbstractObjectiveTo research into the morbidity and characteristics of hyperbilirubinemia which develops among the G6PD (glucose6 phosphate dehydrogenate) deficiency neonates.

(14) Objective To study the effect of blood glucose test in neonatal hyperbilirubinemia.

(15) Objective To explore the feasibility of continuous blue light treatment of neonatal hyperbilirubinemia.

(16) Objective : To evaluate the therapeutic efficacy of synchronous exchange transfusion on hyperbilirubinemia.

(17) These findings demonstrate the varied involvement of peripheral hearing and central brainstem functions in the neurotoxicity of neonatal hyperbilirubinemia.

(18) Objective To investigate effects caused by total exchange transfusion on blood gas, electrolyte, and biochemistry metabolism in the neonate with septemia or hyperbilirubinemia.

(19) ObjectiveTo observe the effect of oxytocin that applicated to the maternals during childbirth on the neonatal hyperbilirubinemia.

(20) Objective:To summarize the use and nursing experience of peripheral artery and vein therapy shake-up in neonatal hyperbilirubinemia to guide clinical work.

(21) To explore the influence of phototherapy on serum calcium of newborn, forty neonatal hyperbilirubinemia patients serum calcium were examined in both groups before and after phototherapy.

(22) Objective : To observe the effects of reduced glutathione on hyperbilirubinemia of newborn of glucose-6-phosphate dehydrogenase deficiency.

(23) Objective To analyse the value of phototherapy in treating neonatal hyperbilirubinemia as well as together with luminal or Yinzhihuang.

(24) Objective To investigate the incidence of hearing disorder and analyse the high-risk factors with hearing injury in newborns with hyperbilirubinemia.

(25) Sound spectral analysis was applied to cry signals of 18 neonates with non - ker - nicterus hyperbilirubinemia.

(26) Objective:To study the value of cord blood micro-bilirubin in early forecasting neonatal hyperbilirubinemia.

(27) Objective To investigate the relationship between the neonatal period hyperbilirubinemia and dyskinetic cerebral palsy.

(28) Objective: To investigate the relationship of caesarean birth and hyperbilirubinemia of newborn.

(29) OBJECTIVE: To observe the therapeutic efficacy of compound glycyrrhizin in the treatment of neonatal hyperbilirubinemia.

(30) Objective To observe the clinical effect of Xiaodan Decoction on hyperbilirubinemia of newborn.

(31) Objectives : To observe the influence of hyperbilirubinemia in the brainstem auditory function of neonates.

(32) Conclusions Prepulside as a supplementary therapy in the treatment of neonatal hyperbilirubinemia promotes the decrease of serum bilirubin levels and shortens the course of treatment.

(33) Objectives : To investigate the effect of two different phototherapy applied to the premature infant unconjugated hyperbilirubinemia.

(34) Objective To research into the morbidity and characteristics of hyperbilirubinemia which develops among the G6PD (glucose-6 phosphate dehydrogenate) deficiency neonates.

(35) Methods: Synchronous blood changing by peripheral arteries (radial or temporal artery) and veins was applied to 45 infants with severe hyperbilirubinemia,() and the improvement was observed.

(36) Preoperative hypoproteinemia and hyperbilirubinemia complicated with a high incidence of postoperative complications on multivariate analysis.

(37) Aim To analyse the clinical characteristic of breast milk jaundice and brain injury caused by hyperbilirubinemia.

(38) ObjectiveTo study the therapeutic effect and feasibility of rectoclysis with Tuihuang decoction (RTD) in treating hyperbilirubinemia of newborns.

(39) Conclusion Glycerine Enema clyster is a simple, effective interventional method to prevent hyperbilirubinemia of newborn.

(40) Conclusions The neonatal hyperbilirubinemia should be early diagnosis, search for a cause to light therapy combined therapy, the prognosis is good.

(41) Objective To analyze the change of constitution ratio and etiological factors on neonatal hyperbilirubinemia.

(42) Objective:To evaluate the clinical values of transcutaneous bilirubin measurements in diagnosis of neonatal hyperbilirubinemia.

(43) Methods Retrospective analysis of 236 causes of neonatal hyperbilirubinemia was made with clinical data.